This inventor holds 38 USPTO granted patents, primarily in Calcitonin Analogs. Top assignees: Armour Pharmaceutical Company, Rorer Pharmaceutical Corporation, Armour Pharmaceutical. Active years: 1982-1991.
Location History:
- Frankfurt, IL (US) (1988)
- Frankfort, IL (US) (1982 - 1991)
Company Filing History:
28 out of 89 
5 out of 109 
2 out of 6 Years Active: 1982-1991
Areas of Expertise:
Title: Innovations and Contributions of Ronald C. Orlowski
Introduction
Ronald C. Orlowski, located in Frankfort, IL, is a notable inventor with an impressive portfolio of 38 patents. His work primarily focuses on the development of novel peptides with significant biological activity, particularly in the field of calcitonins. His innovative contributions have advanced our understanding and application of peptide chemistry.
Latest Patents
Among his recent patents, one notable invention is the "Des-17-histidine-calcitonin." This patent reveals new peptides that maintain biological activity similar to known calcitonins while omitting the histidine at position 17. Furthermore, it describes resin peptides that can be converted into these biologically active peptides, alongside processes for the production of both resin and calcitonin peptides. Another significant patent is the "19-Alanine calcitonin," where new peptides are designed to have an alanine in position 19 instead of the traditional leucine or phenylalanine found in that position. Similar to the previous invention, it also discusses resin peptides and production processes.
Career Highlights
Ronald C. Orlowski has made significant strides in the pharmaceutical industry through his work at established companies such as Armour Pharmaceutical Company and Rorer Pharmaceutical Corporation. His experience in these organizations has contributed to his depth of knowledge and expertise in peptide development.
Collaborations
Throughout his career, Orlowski has collaborated with prominent individuals in his field. Notably, he has worked alongside Jay K. Seyler and Glenn L. Stahl, who have also contributed to the advancement of pharmaceutical innovations.
Conclusion
Ronald C. Orlowski’s contributions in the realm of peptide innovation have been invaluable. With 38 patents to his name, his work has paved the way for new advancements in biomedical research and therapeutics. His dedication to innovation continues to inspire future discoveries in the field.